Synthesis, in‐vitro and in‐silico study of novel thiazoles as potent antibacterial agents and MurB inhibitors.
- Published in:
- Archiv der Pharmazie, 2020, v. 353, n. 4, p. 1, doi. 10.1002/ardp.201900309
- By:
- Publication type:
- Article
Works matching IS 03656233 AND DT 2020 AND VI 353 AND IP 4
Results: 10
1
2
Synthesis and biological evaluation of pyrazolone analogues as potential anti‐inflammatory agents targeting cyclooxygenases and 5‐lipoxygenase.
- Published in:
- Archiv der Pharmazie, 2020, v. 353, n. 4, p. 1, doi. 10.1002/ardp.201900308
- By:
- Publication type:
- Article
3
Novel pyrazolo[3,4‐d]pyrimidine derivatives inhibit human cancer cell proliferation and induce apoptosis by ROS generation.
- Published in:
- Archiv der Pharmazie, 2020, v. 353, n. 4, p. 1, doi. 10.1002/ardp.201900296
- By:
- Publication type:
- Article
4
Editorial Board: Arch. Pharm. (4/2020).
- Published in:
- Archiv der Pharmazie, 2020, v. 353, n. 4, p. 1, doi. 10.1002/ardp.202070008
- Publication type:
- Article
5
Cover Picture: Arch. Pharm. (4/2020).
- Published in:
- Archiv der Pharmazie, 2020, v. 353, n. 4, p. 1, doi. 10.1002/ardp.202070007
- Publication type:
- Article
6
Chalcone hybrids and their antimalarial activity.
- Published in:
- Archiv der Pharmazie, 2020, v. 353, n. 4, p. 1, doi. 10.1002/ardp.201900350
- By:
- Publication type:
- Article
7
Design, synthesis, and molecular docking of novel 2‐arylbenzothiazole multiangiokinase inhibitors targeting breast cancer.
- Published in:
- Archiv der Pharmazie, 2020, v. 353, n. 4, p. 1, doi. 10.1002/ardp.201900340
- By:
- Publication type:
- Article
8
A new sensitive and subunit‐selective molecular tool for investigating protein kinase A in the brain.
- Published in:
- Archiv der Pharmazie, 2020, v. 353, n. 4, p. 1, doi. 10.1002/ardp.201900326
- By:
- Publication type:
- Article
9
Novel pyrazolopyrimidine urea derivatives: Synthesis, antiproliferative activity, VEGFR‐2 inhibition, and effects on the cell cycle profile.
- Published in:
- Archiv der Pharmazie, 2020, v. 353, n. 4, p. 1, doi. 10.1002/ardp.201900319
- By:
- Publication type:
- Article
10
3′‐(4‐(Benzyloxy)phenyl)‐1′‐phenyl‐5‐(heteroaryl/aryl)‐3,4‐dihydro‐1′H,2H‐[3,4′‐bipyrazole]‐2‐carboxamides as EGFR kinase inhibitors: Synthesis, anticancer evaluation, and molecular docking studies
- Published in:
- Archiv der Pharmazie, 2020, v. 353, n. 4, p. 1, doi. 10.1002/ardp.201900262
- By:
- Publication type:
- Article